Search
for
Sort by
Research 661–690 of 709
- Successful Treatment of Alopecia Areata Barbae with Platelet-rich Plasma
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis
- Efficacy and safety of baricitinib in patients with refractory alopecia areata
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- A Case Report of the Retreatment with the Same Herbal Medicine after the Treatment of Alopecia Areata in a Child
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Janus kinase inhibitors for alopecia areata: A narrative review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Retrospective Study about the Effectiveness of Korean Medical Treatment on 222 Patients with Alopecia Areata
- Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990–2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021
- The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- Clinical and epidemiological features of atopic type of alopecia areata
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- A comparative study of fractional CO2 laser with topical triamcinolone acetonide versus intralesional triamcinolone acetonide in the treatment of alopecia areata
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- A Retrospective Study on Alopecia Areata in Children: Clinical Characteristics and Treatment Choices
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review
- Review of Promising Off-Label Use of Deucravacitinib
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Knowledge, attitudes, and practices toward disease management among alopecia areata patients
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto’s Disease, and Addison’s Disease